Detalhe da pesquisa
1.
Beyond Skin Rash: Alpelisib-Induced Anaphylactic Reactions.
Oncologist
; 28(7): e493-e497, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086483
2.
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours.
BMC Cancer
; 23(1): 205, 2023 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36870947
3.
WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer: A biomarker-enriched phase II study.
Gynecol Oncol
; 174: 239-246, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37236033
4.
Mutational profiles associated with resistance in patients with BRAFV600E mutant colorectal cancer treated with cetuximab and encorafenib +/- binimetinib or alpelisib.
Br J Cancer
; 124(1): 176-182, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33204026
5.
Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic Cancer.
Oncologist
; 26(4): 290-e545, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33296125
6.
Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer.
Br J Cancer
; 122(8): 1166-1174, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32147669
7.
Supporting Patients with Cancer after Dobbs v. Jackson Women's Health Organization.
Oncologist
; 2022 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35962750
8.
The Use of Microdosing for In vivo Phenotyping of Cytochrome P450 Enzymes: Where Do We Stand? A Narrative Review.
Eur J Drug Metab Pharmacokinet
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38689161
9.
Is Higher Docetaxel Clearance in Prostate Cancer Patients Explained by Higher CYP3A? An In Vivo Phenotyping Study with Midazolam.
J Clin Pharmacol
; 64(2): 155-163, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37789682
10.
A proof-of-concept study of sequential treatment with the HDAC inhibitor vorinostat following BRAF and MEK inhibitors in BRAFV600mutated melanoma.
Clin Cancer Res
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739109
11.
A Phase I, Open-Label, Dose Confirmation, Escalation, and Expansion Trial of BI 1810631 as Monotherapy in Patients With Advanced or Metastatic Solid Tumors With HER2 Aberrations.
Clin Lung Cancer
; 24(2): e65-e68, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36528522
12.
Clinical development of WEE1 inhibitors in gynecological cancers: A systematic review.
Cancer Treat Rev
; 115: 102531, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36893690
13.
Pharmacokinetic boosting of olaparib: A randomised, cross-over study (PROACTIVE-study).
Eur J Cancer
; 194: 113346, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37806255
14.
First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1).
J Immunother Cancer
; 11(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36927527
15.
Lapatinib for advanced or metastatic breast cancer.
Oncologist
; 17(4): 536-42, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22477724
16.
Knee arthroplasty and risk of hip fracture: a population-based, case-control study.
Calcif Tissue Int
; 90(2): 144-50, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22179584
17.
The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology.
Nat Cancer
; 3(2): 251-261, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35221333
18.
Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer.
Cancer Chemother Pharmacol
; 85(5): 917-930, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32274564
19.
Design, validation and performance of aspartate aminotransferase- and lactate dehydrogenase-reporting algorithms for haemolysed specimens including correction within quality specifications.
Ann Clin Biochem
; : 4563219878475, 2019 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31495183
20.
Cholinesterase inhibitor treatment in patients with delirium.
Lancet
; 377(9769): 900-1; author reply 901, 2011 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-21397759